1. Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? 
Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan Xiong, MS, Jay Lin, PhD, Prajesh Kothawala, MD, MPH, Matthew Emons, MD, MBA 
The American Journal of Medicine 
Volume 123, Issue 5, Pages (May 2010)
DOI: /j.amjmed
Copyright © 2010 Elsevier Inc. Terms and Conditions

2. Figure 1 Patients meeting study inclusion/exclusion criteria.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © 2010 Elsevier Inc. Terms and Conditions

3. Figure 2
Patients stratified by CHADS2 (Congestive heart failure, Hypertension, Age >75 years, Diabetes, Stroke) score.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © 2010 Elsevier Inc. Terms and Conditions

4. Figure 3
Warfarin use within 30 days of first recorded atrial fibrillation/flutter diagnosis, by stroke risk level. *Hatched area represents the proportion of patients with uninterrupted therapy over 180 days following their initial warfarin prescription. CHADS2=Congestive heart failure, Hypertension, Age >75 years, Diabetes, Stroke score.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © 2010 Elsevier Inc. Terms and Conditions